Emerging Challenges for Psychedelic Therapy

JAMA Psychiatry. 2023 Jun 1;80(6):533-534. doi: 10.1001/jamapsychiatry.2023.0549.

Authors

Jacob S Aday¹, Robin L Carhart-Harris¹, Joshua D Woolley^{1

2}

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.
² San Francisco Veterans Affairs Medical Center, San Francisco, California.

PMID: 37074690
DOI: 10.1001/jamapsychiatry.2023.0549

No abstract available

Plain language summary

This Viewpoint examines the benefits and challenges of psychedelic therapy using 4 fundamental questions.

MeSH terms

Hallucinogens* / therapeutic use
Humans

Substances

Hallucinogens